Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

被引:533
作者
Knappik, A
Ge, LM
Honegger, A
Pack, P
Fischer, M
Wellnhofer, G
Hoess, A
Wölle, J
Plückthun, A
Virnekäs, B
机构
[1] MorphoSys AG, D-82152 Munich, Germany
[2] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland
关键词
human antibodies; phage display library; combinatorial immunoglobulin repertoire; antibody expression; trinucleotide mutagenesis;
D O I
10.1006/jmbi.1999.3444
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By analyzing the human antibody repertoire in terms of structure, amino acid sequence diversity and germline usage, we found that seven V-H and seven V-L (four V kappa and three V lambda) germline families cover more than 95 % of the human antibody diversity used. A consensus sequence was derived for each family and optimized for expression in Escherichia coli. In order to make all six complementarity determining regions (CDRs) accessible for diversification, the synthetic genes were designed to be modular and mutually compatible by introducing unique restriction endonuclease sites flanking the CDRs. Molecular modeling verified that all canonical classes were present. We could show that all master genes are expressed as soluble proteins in the periplasm of E. coli. A first set of antibody phage display libraries totalling 2 x 10(9) members was created after cloning the genes in all 49 combinations into a phagemid vector, itself devoid of the restriction sites in question. Diversity was created by replacing the V-H and V-L CDR3 regions of the master genes by CDR3 Library cassettes, generated from mixed trinucleotides and biased towards natural human antibody CDR3 sequences. The sequencing of 257 members of the unselected libraries indicated that the frequency of correct and thus potentially functional sequences was 61 %. Selection experiments against many antigens yielded a diverse set of binders with high affinities. Due to the modular design of all master genes, either single binders or even pools of binders can now be rapidly optimized without knowledge of the particular sequence, using pre-built CDR cassette libraries. The small number of 49 master genes will allow future improvements to be incorporated quickly, and the separation of the frameworks may help in analyzing why nature has evolved these distinct subfamilies of antibody germline genes. (C) 2000 Academic Press.
引用
收藏
页码:57 / 86
页数:30
相关论文
共 119 条
[1]   Standard conformations for the canonical structures of immunoglobulins [J].
AlLazikani, B ;
Lesk, AM ;
Chothia, C .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 273 (04) :927-948
[2]   Structural differences between the repertoires of mouse and human germline genes and their evolutionary implications [J].
Almagro, JC ;
Hernández, I ;
Ramírez, MD ;
Vargas-Madrazo, E .
IMMUNOGENETICS, 1998, 47 (05) :355-363
[3]  
Baca M, 1997, J BIOL CHEM, V272, P10678
[4]   Selection and evolution of high-affinity human anti-viral antibodies [J].
Barbas, CF ;
Burton, DR .
TRENDS IN BIOTECHNOLOGY, 1996, 14 (07) :230-234
[5]   SEMISYNTHETIC COMBINATORIAL ANTIBODY LIBRARIES - A CHEMICAL SOLUTION TO THE DIVERSITY PROBLEM [J].
BARBAS, CF ;
BAIN, JD ;
HOEKSTRA, DM ;
LERNER, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4457-4461
[6]   SELECTION OF HUMAN ANTIHAPTEN ANTIBODIES FROM SEMISYNTHETIC LIBRARIES [J].
BARBAS, CF ;
AMBERG, W ;
SIMONCSITS, A ;
JONES, TM ;
LERNER, RA .
GENE, 1993, 137 (01) :57-62
[7]   RECOGNITION OF DNA BY SYNTHETIC ANTIBODIES [J].
BARBAS, SM ;
GHAZAL, P ;
BARBAS, CF ;
BURTON, DR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (05) :2161-2162
[8]   The Human Immunoglobulin Kappa Variable (IGKV) Genes and Joining (IGKJ) Segments [J].
Barbié, V ;
Lefranc, MP .
EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1998, 15 (03) :171-183
[9]   STRUCTURAL CONSERVATION OF HYPERVARIABLE REGIONS IN IMMUNOGLOBULINS EVOLUTION [J].
BARRE, S ;
GREENBERG, AS ;
FLAJNIK, MF ;
CHOTHIA, C .
NATURE STRUCTURAL BIOLOGY, 1994, 1 (12) :915-920
[10]  
Baskin B, 1998, CLIN EXP IMMUNOL, V112, P44